Formosa Pharmaceuticals Partners with Rxilient to Launch Innovative Ophthalmic Suspension in ASEAN Formosa Pharmaceuticals announces a groundbreaking partnership with Rxilient for the commercialization of an innovative ophthalmic treatment. This collaboration aims to enhance patient care after ocular surgeries in key ASEAN markets.

Formosa Pharmaceuticals Partners with Rxilient to Launch Innovative Ophthalmic Suspension in ASEAN #Taiwan #Taipei #Formosa_Pharmaceuticals #Rxilient #APP13007

Formosa Pharmaceuticals and Adalvo Limited Collaborate for Ocular Pain Relief Treatment Formosa Pharmaceuticals has entered an exclusive agreement with Adalvo Limited for a groundbreaking treatment aimed at ocular inflammation and pain relief.

Formosa Pharmaceuticals and Adalvo Limited Collaborate for Ocular Pain Relief Treatment #Taiwan #Taipei #Formosa_Pharmaceuticals #Clobetasol_Propionate #Adalvo_Limited

Formosa Pharmaceuticals Partners with Apotex to Launch New Ocular Treatment in Mexico Formosa Pharmaceuticals has partnered with Apotex to bring an innovative ocular treatment to the Mexican market, enhancing post-surgery recovery options.

Formosa Pharmaceuticals Partners with Apotex to Launch New Ocular Treatment in Mexico #Taiwan #Taipei #Formosa_Pharmaceuticals #Clobetasol_Propionate #Apotex_Inc

Apotex Expands Licensing Agreement for Clobetasol Propionate in Mexico Apotex Inc. has announced an exclusive licensing arrangement with Formosa Pharmaceuticals for clobetasol propionate in Mexico to treat post-surgical ocular conditions.

Apotex Expands Licensing Agreement for Clobetasol Propionate in Mexico #Mexico #Mexico_City #Formosa_Pharmaceuticals #Apotex #Clobetasol

Formosa Pharmaceuticals Partners with Saval Corporation to Advance Innovative Ophthalmic Treatment Formosa Pharmaceuticals has secured an exclusive licensing deal with Saval Corporation for a groundbreaking ophthalmic suspension, set to revolutionize post-operative care.

Formosa Pharmaceuticals Partners with Saval Corporation to Advance Innovative Ophthalmic Treatment #Taiwan #Taipei #Formosa_Pharmaceuticals #Clobetasol_Propionate #Saval_Corporation

Formosa Pharmaceuticals Teams Up with Medvisis for Clobetasol Propionate Licensing in Switzerland Taiwan's Formosa Pharmaceuticals collaborates with Medvisis Switzerland for exclusive rights to market Clobetasol Propionate, enhancing post-operative care.

Formosa Pharmaceuticals Teams Up with Medvisis for Clobetasol Propionate Licensing in Switzerland #Taiwan #Taipei #Formosa_Pharmaceuticals #Clobetasol_Propionate #Medvisis_Switzerland